ADAR inhibitor

This page covers all ADAR inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ADAR1 and/or ADAR2.

Targets

ADAR1 and/or ADAR2

Phase 3 pipeline (1)

• ADX-324 Dose Level 1 · ADARx Pharmaceuticals, Inc. · Immunology / Autoimmune
  ADX-324 is an ADAR inhibitor that reduces adenosine-to-inosine RNA editing to modulate immune and inflammatory responses.

Patent intelligence

• adar inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates